Simplex Trading, LLC Cytek Biosciences, Inc. Transaction History
Simplex Trading, LLC
- $2.81 Billion
- Q3 2024
A detailed history of Simplex Trading, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,440 shares of CTKB stock, worth $9,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,440
Previous 1,490
3.36%
Holding current value
$9,244
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CTKB
# of Institutions
134Shares Held
72MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$110 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$75.6 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$60.9 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$42.7 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$26.8 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $864M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...